KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for Bristol Myers Squibb (BMY) over the last 5 years, with Q3 2025 value amounting to $1.7 billion.

  • Bristol Myers Squibb's Change in Accured Expenses fell 637.71% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 750.89%. This contributed to the annual value of $1.5 billion for FY2024, which is 6415.93% up from last year.
  • Bristol Myers Squibb's Change in Accured Expenses amounted to $1.7 billion in Q3 2025, which was down 637.71% from $881.0 million recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Change in Accured Expenses peaked at $1.8 billion during Q3 2024, and registered a low of -$930.0 million during Q1 2022.
  • Moreover, its 5-year median value for Change in Accured Expenses was $215.0 million (2021), whereas its average is $296.6 million.
  • Data for Bristol Myers Squibb's Change in Accured Expenses shows a peak YoY increase of 14186.05% (in 2022) and a maximum YoY decrease of 67692.31% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Change in Accured Expenses stood at -$39.0 million in 2021, then crashed by 676.92% to -$303.0 million in 2022, then soared by 30.36% to -$211.0 million in 2023, then crashed by 91.94% to -$405.0 million in 2024, then skyrocketed by 520.49% to $1.7 billion in 2025.
  • Its Change in Accured Expenses stands at $1.7 billion for Q3 2025, versus $881.0 million for Q2 2025 and -$627.0 million for Q1 2025.